Background: Nontyphoidal Salmonellae frequently cause life-threatening bacteremia in sub-Saharan Africa. Young children and HIV-infected adults are particularly susceptible. High case-fatality rates and increasing antibiotic resistance require new approaches to the management of this disease. Impaired cellular immunity caused by defects in the T helper 1 pathway lead to intracellular disease with Salmonella that can be countered by IFNc administration. This report identifies the lymphocyte subsets that produce IFNc early in Salmonella infection.
Introduction
Nontyphoidal strains of Salmonella (NTS), in particular Salmonella enterica Typhimurium and Enteritidis (S. Typhimurium and S. Enteritidis) are a major cause of invasive disease, especially bacteremia and meningitis, in Africa [1, 2, 3, 4, 5, 6, 7, 8, 9, 10] . Children under two years of age [3, 6, 8] and HIV-infected adults [7, 9] are particularly susceptible and case-fatality rates for NTS bacteremia are high, being over 20% in children [6, 8] and up to 50% in adults [7] . A lack of typical clinical presentation for invasive NTS disease and affordable timely diagnostics [6, 8, 11] , together with increasing levels of multidrug resistance [4, 5, 11, 12] underlie the urgent need for new approaches to treat NTS.
In order to develop a vaccine against NTS, an improved understanding of the relevant modalities of protective immunity is required. We have previously shown the importance of antibody for complement-mediated cell-independent killing of NTS in the peripheral blood of young African children [3] . This protection can be lost in HIV-infected adults due to the presence of high titers of anti-LPS antibodies that block killing of Salmonella by antibodies against outer membrane proteins [13] . In addition to their capacity for extracellular survival, Salmonellae are facultative intracellular bacteria and their ability to survive within cells is essential for virulence [14] . The high susceptibility of individuals with chronic granulomatous disease, who lack normal phagocyte oxidative burst function, to infection with Salmonellae [15, 16] indicates the importance of cellular immune mechanisms against Salmonella in man. Therefore it is likely that control of intracellular infection moderates release of bacteria into body fluids and hence the dependence on antibodies against outer membrane proteins that protect against extracellular disease. Effective protection by a vaccine is likely to be achieved best by eliciting both these elements without inducing blocking antibodies. We have also recently demonstrated the importance of antibody acting as an opsonin for phagocyte cellular immunity against NTS in African children [17] .
It is well established that IFNc is a key cytokine for inducing mouse [18, 19, 20] and human [21, 22] macrophages to kill Salmonella through both oxidative burst and nonoxidative mechanisms. The importance of IFNc in immunity to Salmonella in man is demonstrated by the heightened susceptibility of individuals with genetic deficiencies in the T helper 1 pathway, also known as the interleukin-(IL)12/23-interferon(IFNc) axis, to recurrent infection with NTS [23, 24, 25, 26] . In those patients where the genetic defect is in the IL-12 or IL-12R genes [27, 28, 29] and in individuals with chronic granulomatous disease [30] , subcutaneous IFNc has successfully been used as an adjunct to antibiotic therapy in the treatment of invasive Salmonella disease. The presence of protective antibodies in these patients is the likely reason for the infections being manifest as local inflammatory lesions rather than fatal bacteremia or meningitis [24] .
Additional support for an essential role for IFNc in immunity to Salmonella comes from the mouse model of Salmonella infection. IFNc-receptor-deficient mice are highly susceptible to attenuated Salmonella Typhimurium [31] , as are mice that have been pretreated with antibodies to IFNc [32, 33, 34, 35] or IL-12 [36] . Administration of recombinant IFNc enhances killing of Salmonella in mice [32] and restores resistance to attenuated Salmonella after depletion of endogenous IL-12 using neutralizing anti-cytokine antibodies [36] . Blood levels of IFNc increase both in Salmonella infections in mice [37, 38, 39, 40, 41] and in humans, particular in the case of systemic disease [42] .
The course of untreated HIV infection is characterized by the loss of CD4 + -T cells. Secretion of T helper 1 cytokines, in particular IFNc, decreases during the course of HIV infection [43] and correlates with CD4 count [44] . There is downregulation of IFNc production in both CD4
+ -and CD8 + -T cell subsets [45] and a switch from a predominantly T helper 1 to a T helper 2 response [46] . In vitro infection of CD4 + -T cells with HIV also results in downregulation of IFNc expression [47] , while commencement of HIV-infected patients on antiretroviral therapy leads to an increase in IFNc production [48] . This reduction in IFNc levels could, at least in part, account for the strong clinical association between invasive NTS disease and HIV/AIDS in Africa.
The clear importance for IFNc in immunity to Salmonella and the ability of multiple lymphocyte subsets to produce this cytokine [24] , led us to study IFNc production in peripheral blood cells of healthy humans. We used intracellular cytokine staining (ICS) to identify the lymphocyte subsets that produce IFNc when stimulated with NTS. We investigated lymphocytes in the innate arm of the immune system that do not use classical MHCrestricted antigen recognition (NK cells, cd-T cells and NK-like T cells) as well as lymphocytes responsible for acquired cellular responses (CD4 + -and CD8 + -T cells). Identification of the cells that secrete this key cytokine will help in the design of new therapies against NTS.
Materials and Methods

Ethical Approval
Ethical approval for the use of anonymized blood samples in this study was granted by the Life and Health Sciences Ethical Review Committee of the University of Birmingham. Informed written consent was obtained from all participants.
Blood samples
Anonymized blood samples were obtained from healthy adults (5 male:5 female; ages 21 to 41 years). Blood samples anticoagulated with sodium heparin at 4 IU/ml and EDTA (collected in EDTAanticoagulated tubes, Becton Dickinson, UK) were used for intracellular cytokine staining (ICS) and conventional immunophenotyping respectively. Serum, separated and stored in aliquots at -80uC immediately after clotting, was used for studies of humoral immunity.
Salmonella
The invasive Malawian S. Typhimurium isolate D23580 was used in all studies. Its genome has been sequenced at the Wellcome Trust Sanger Institute [12] . For experiments involving live Salmonella, D23580 was grown to log phase, washed twice with phosphate buffered saline (PBS) and added to heparin-anticoagulated whole blood or serum at 1/10 th of the final volume giving 10 6 viable bacteria/ml. When required, the bacteria were heat-killed by incubating at 72uC for one hour. In the flow-cytometric antibody assay, D23580 in log growth phase was fixed with 1% formaldehyde in PBS. A whole-cell homogenate of D23580 was produced by disrupting washed D23580 using a Mini-Beadbeater (Biospec Products) as previously described [49] . This homogenate, at a final concentration of 10 mg/ml, was used to stimulate cells in heparinizedwhole blood. Protein content of homogenates was determined by bicinchoninic acid (BCA) protein assay (Thermo Scientific).
Intracellular cytokine staining
Half ml aliquots of heparin-anticoagulated blood were stimulated with S. Typhimurium D23580 within one hour of collection in 15 ml tubes at 37uC for six hours unless otherwise specified. At the time of stimulation, 5 ml CD28/CD49d co-stimulatory antibodies (Becton Dickinson) was added to each tube, including control tubes, in order to ensure that lack of costimulation did not limit the production of cytokines, in particular, by ab-T cells. 10 ml Brefeldin A (Becton Dickinson) diluted 1:10 with PBS was added to each tube after 2 hours. As positive control, blood was stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin (both Sigma, UK) at final concentrations of 10 ng/ml and 1 mg/ml respectively. Negative control tubes were stimulated with PBS in place of Salmonella.
After the six hour stimulation period, adherent cells were resuspended by the addition of 50 ml EDTA (Becton Dickinson) to each tube. 50 ml aliquots of stimulated blood were incubated with a three-color panel of monoclonal antibodies (all Becton Dickinson) to the following cell-surface antigens in order to discriminate lymphocyte subsets and activated cells: PerCP-Cy5. 5 
CD56
+ lymphocytes.
Immunophenotyping
Conventional immunophenotyping for lymphocyte subset analysis was performed on 50 ml samples of EDTA-anticoagulated blood as previously described using the following combinations of monoclonal antibodies (all Becton Dickinson): 1) TCRcd-FITC, CD4-PE, CD8-PerCP-Cy5.5, CD3-APC; 2) CD56-PE, CD3-PerCP-Cy5.5, CD19-APC. Sample data were acquired and analyzed on a FACSCalibur flow cytometer using CellQuest Pro software. Tube 2 was also used for internal quality assurance to check that the sum of T, B and NK lymphocyte subset percentages was within 10066%. Absolute lymphocyte subset counts were calculated as the product of the subset percentage and total lymphocyte count determined on a standard laboratory hematological analyzer.
Monocyte activation assay
The ability of IFNc, produced during the stimulation of whole blood with Salmonella, to activate monocytes, was assessed by stimulating fresh blood with plasma prepared from the whole blood stimulations and measuring CD38 expression on monocytes in these fresh blood samples. In order to allow the secretion of newlysynthesized IFNc into the plasma, whole blood (or plasma, as control) was stimulated with Salmonella or PBS (negative control) as described above, but without the addition of Brefeldin A. After six hours, plasmas were collected by centrifugation and bacteria removed by sterilizing through 0.2 mm filters. 200 ml of each plasma was added to 500 ml fresh heparin-anticoagulated blood and incubated at 37uC for five hours. 50 ml samples of blood were labeled as described above, but using CD38-PE and CD14-APC antibodies. Monocytes were discriminated by CD14 against sidescatter histogram, and CD38 expression designated as the geometric mean fluorescent intensity (GMFI) in the FL2 histogram.
Serum bactericidal assay and anti-Salmonella antibody assay
The serum bactericidal assay for the ability of serum to kill S. Typhimurium D23580 and flow cytometric assay for measurement of titer of anti-D23580 IgG and IgM were as previously described [3] . Briefly, viable D23580 in log growth phase at a 1/ 10 th volume was added to serum in a final volume of 100 ml and final concentration of 10 6 cfu/ml. Killing of Salmonella at 37uC was measured over a three hour time course. For Salmonella-specific antibody determination, serum diluted 1:10 with PBS was mixed with 1/10 th volume of formaldehyde-fixed D23580 at a final concentration of 2610 8 bacteria/ml, prior to detection of bound antibody with FITC-conjugated anti-human IgG and IgM (Sigma) and acquisition and analysis of data by flow cytometry.
Statistical methods
Student's t test was used to compare percentages and absolute numbers of IFNc-producing cells in different lymphocyte subsets. Log-transformation was used to normalize absolute cell counts within subsets.
Results
Detection of IFNc-production by peripheral blood lymphocytes in response to stimulation with Salmonella using an optimized intracellular cytokine staining technique
We looked for IFNc production by healthy adult peripheral blood lymphocytes stimulated with S. Typhimurium homogenate and PMA (Figure 1 ). Background numbers of IFNc-producing cells were typically less than 0.1% ( Figure 1A-B) , while positive control PMA-stimulated cells gave responses of between 20% and 50% IFNc-producing cells (Figure 1C-D) . Cells producing IFNc in response to stimulation with NTS also expressed the early activation antigen CD69, though not all CD69
+ lymphocytes produced IFNc (Figure 1E-F) .
Kinetics of IFNc production by peripheral blood lymphocytes in response to stimulation with Salmonella IFNc production by different lymphocyte subsets was examined in relation to duration of stimulation with Salmonella homogenate in the blood of healthy adult donors using the ICS method described (Figure 2 ). Little, if any, cytokine production was detected after two hours of stimulation, though by four hours IFNc production was present in cells of all four subsets examined: CD4
+ -and cd-T cells, and NK cells. The percentage of IFNcproducing cells plateaued at six hours for CD8
+ -and cd-T cells, and NK cells ( Figure 2B-D) . By contrast, this percentage continued to increase over the next two hours for CD4
+ -T cells (Figure 2A ). Based on these findings, we choose to stimulate blood with Salmonella for six hours in subsequent ICS assays. The percentage of IFNc-producing cells was markedly higher in the cd-T cells and NK cells subsets compared with CD4
+ -and CD8 + -T cells.
Immunity to Salmonella in peripheral blood from healthy adult donors
In order to provide an indication of the prior immunity and/or exposure to NTS in the ten anonymized healthy adult blood donors, we performed flow cytometric antibody assays to determine titers of IgG and IgM against S. Typhimurium isolate D23580 and serum bactericidal assays with D23580 ( Figure 3 ). Sera from all ten donors contained anti-D23580 antibodies (.1.5 U) in the form of IgG or IgM or both classes of antibody. All sera were able to effect an approximately 90% or greater kill (1 log10 kill) of Salmonella in the serum bactericidal assay indicating that these anti-Salmonella antibodies are functional.
IFNc-production by peripheral blood lymphocyte subsets in response to stimulation with Salmonella IFNc-production by peripheral blood lymphocyte subsets in response to stimulation with live compared with heatkilled Salmonella
Previous reports indicate a difference in immune response to Salmonella depending on whether the bacteria are alive or dead [39, 50, 51] . To assess this in the context of the current study, IFNc production by lymphocyte subsets stimulated with heat-killed D23580 was compared to that by cells stimulated with live D23580 ( Figure 4B ). No significant difference was found in the percentage of IFNc-producing cells in each lymphocyte subset (t test, P.0.2), except for cd-T cells where markedly reduced IFNc-producing cells were generated by stimulation with dead bacteria (t test, P,0.0001).
Ability of IFNc produced by peripheral blood lymphocytes to stimulate blood monocytes
In order to give an indication of whether IFNc produced by peripheral blood lymphocytes in the ICS assays was functional, we measured the ability of plasmas from whole blood stimulated with Salmonella to activate monocytes. CD38 was chosen as an indicator of monocyte activation, because it is strongly upregulated on human monocytes by IFNc, but not by other monocyte-activating factors, including other cytokines such as TNFa and GM-CSF, and bacterial components such as LPS [52] . Surface expression of CD38 on monocytes in four blood samples was measured by flow cytometry following 5 hours of stimulation with plasmas derived from Salmonella-whole blood stimulation assays. Mean GMFI expression of CD38 was 469 compared with 352 for monocytes from blood samples stimulated with plasma from unstimulated blood (negative control) (P = 0.004) ( Figure 5) .
In order to ensure that raised CD38 expression was not due to direct bacterial stimulation, plasmas from whole blood stimulation assays were sterilized through 0.2 mm filters before adding to fresh blood samples. To confirm that bacterial components such as LPS in the plasmas were not the cause of raised monocyte CD38 expression, we also stimulated fresh whole blood with plasma samples that had been separated from cells prior to incubating with Salmonella for 6 hours (plasma control). Mean CD38 expression on monocytes from these samples was 374 and was significantly lower than observed with blood stimulated by plasmas collected from whole blood stimulated with Salmonella (P = 0.0001), but was no different to CD38 expression on monocytes in blood incubated with plasma from unstimulated blood ( Figure 5 ).
Absolute numbers of IFNc-producing lymphocytes in peripheral blood in response to stimulation with Salmonella
While our experiments so far show the proportion of lymphocytes in each subset producing IFNc, we wanted to determine the absolute numbers of IFNc-producing cells for each lymphocyte subset in peripheral blood. To do this, we first measured the absolute numbers of each lymphocyte subset, calculated from the percentage of each subset within the lymphocyte population by conventional immunophenotyping and the total lymphocyte count from the hematological analyzer. Then, the absolute numbers of IFNc-producing lymphocytes was assessed as the product of each absolute count and percentage IFNc-producing cells (Table 1) .
Geometric mean absolute counts for IFNc-producing cells were approximately 10-fold lower for CD4 + -T cells (1 cell/ml) and CD8
+ -T cells (3 cells/ml) compared with the innate/innate-like subsets (cd-T cells 14 cell/ml, NK cells 25 cells/ml, NK-like T cells 5 cells/ml)
. Although a wide range of total IFNc-producing lymphocytes (16 to 278 cells/ml) was found in peripheral blood across the ten donors, absolute numbers of IFNc-producing lymphocytes in innate/innate-like subsets were significantly higher than those in the adaptive subsets (geometric means: 50 compared with 7 cells/ml, t test P,0.001).
Discussion
In the present study, we have used intracellular cytokine staining to examine the production of IFNc by different lymphocyte subsets in response to stimulation with S. Typhimurium D23580, a well-characterized invasive African strain of NTS [12] . Having previously established an importance for antibody in protecting against NTS in Africans [3, 17] , we wanted to investigate the cellular arm of the immune response to Salmonella in man. Since T helper 1 cell immunity is key for protection against invasive Salmonella disease [24] and IFNc is the preeminent effector T helper 1 cytokine, we focused our attention on production of this cytokine.
Our choice of studying cytokine production in ex vivo peripheral blood was partly pragmatic, in view of the limited scope for in vivo studies of infection in man. Since the commonest presentation of invasive NTS disease in Africans is bacteremia, in vitro study of infection in peripheral blood arguably provides a reasonable model of this clinical problem. It could also be argued that a principal requirement for IFNc in Salmonella infection is within the secondary lymphoid tissues, particularly in the context of recurrent intracellular infection observed in individuals with genetic T helper 1 pathway deficiencies. Investigation of IFNc levels in man in such tissues would be difficult to conduct. The relatively short duration of the experimental model (hours as opposed to days) reflects the rapid time-course of invasive NTS disease in vivo. Approximately half of all African children who die from acute NTS bacteremia do so within the first 24 to 48 hours of admission (unpublished findings). This is similar to the length of time Previous studies on cytokine production in response to Salmonella infection have tended to focus on a limited number of lymphocyte subsets and few studies have been performed on human tissue. We wanted to understand the immune response of a broader range of lymphocyte subsets. In particular, we sought to examine whether there were differences in responses between the innate/innate-like subsets compared to lymphocyte subsets of the acquired immune response (the TCR-ab lymphocytes). Further subdivision of these subsets could be performed with a flow cytometer equipped with more than four fluorescence detector channels. Nevertheless, the panel of markers used in this study permitted us to differentiate the principle subsets of the T and NK lymphocyte lineages and to distinguish between innate and adaptive cells. Since lymphocyte subset sizes can vary considerably between individuals [53] , we also wanted to determine absolute as well as relative numbers of IFNc-producing cells in response to stimulation with Salmonella.
The principle finding of this study is the high inherent capacity within the innate immune system for IFNc production relative to the adaptive immune system in response to NTS, even when peripheral blood from adults with evidence of existing immunity and/or prior exposure to Salmonella is examined. This latter point is important, since it reduces the possibility that the relative lack of acquired lymphocytes responsive to Salmonella was the result of immune naivety towards Salmonella, though higher levels of Salmonella-specific ab-T lymphocytes would be expected among Africans where exposure to Salmonella is likely to be much higher. In relation to percentages of cells in each subset that produce IFNc, cd-T cells, NK cells and NK-like T cells had significantly higher percentages of IFNc-producing cells than CD4 + -and CD8 + -T cells. Given their smaller overall sizes, it is even more striking that when absolute cell counts are examined, the numbers of IFNc-producing innate/innate-like subsets are still dominant. Geometric mean values for IFNc-producing cell counts in the innate/innate-like subsets (14, 25 and 8 cells/ml) are higher than those for the classical adaptive subsets (1 and 3 cells/ml), with a 7-fold overall difference in IFNc-producing cells between the two broad categories (7 cells/ml for adaptive lymphocytes and 50 cells/ ml for innate/innate-like cells).
Whilst our understanding of Salmonella infections in individuals with genetic deficiencies of the T helper 1 pathway demonstrates the importance of T helper 1 immunity and IFNc for protection against Salmonella, it does not indicate which of the IFNcproducing cell subsets are needed for this protection. Our finding of capacity within the innate system for IFNc production suggests that during acute infections with Salmonella, this capacity may suffice and priming of the acquired T cell response through prior exposure/infection or vaccination may not be essential. The functionality of the secreted IFNc demonstrated by the upregulation of CD38 expression on blood monocytes adds further significance to these observations. Using the mouse model of Salmonella infection, IFNc production has been demonstrated in a variety of individual lymphocyte subsets. A strong T helper 1 response is characteristic of S. Typhimurium infection in the mouse, with a large expansion in numbers of activated IFNc-secreting CD4 + -and CD8 + -T cells in the blood, though this response takes a week to develop during primary infection [54, 55, 56] . However, splenic cells from mice with severe combined immunodeficiency (SCID) that lack T cells produce elevated levels of IFNc after stimulation with S. Typhimurium [57] , suggesting that NK or other innate cells are responsible for IFNc production. NK cell numbers are elevated post infection with Salmonella [58, 59, 60] and are an early source of IFNc [59] and mice depleted of NK cells show diminished Figure 5 . Effect of plasma from Salmonella stimulation of whole peripheral blood on monocyte CD38 expression. Plasma from S. Typhimurium-stimulated whole blood (NTS stimulated) was separated and filter-sterilized prior to adding to fresh blood for five hours followed by measurement of CD38 expression on monocytes. CD38 expression was significantly higher than for blood incubated with plasma taken from unstimulated blood (NC) or for blood incubated with plasma stimulated with NTS in the absence of cells (plasma control resistance to Salmonella infection [58, 61] . Human NK cells have also been shown to produce IFNc in vitro in response to stimulation with Salmonella and to clear macrophages of Salmonella infection [61] .
An important subset in the innate response to NTS is the cd-T cell subset. Since these cells can produce both innate and adaptive responses, it is probably more accurate to describe them as 'innatelike', since although in the current study they are most likely mounting an innate response, they have the capacity to respond specifically through their T cell receptors. Expansion of the cd-T cell subset in peripheral blood has been found during Salmonella infection in man, particularly with systemic disease [62] , as has enlargement of the NK-like T cell subset [63] . cd-T cells from patients with Salmonella infection produce high levels of IFNc [42] . Likewise, increased numbers of cd-T cells are found in murine salmonellosis [60, 64, 65, 66] , particularly in the peritoneal cavity, and these produce IFNc in response to Salmonella-infected macrophages. Depletion of cd-T cells in the mouse results in increased susceptibility to Salmonella infection [67] .
While the response of other subsets investigated was independent of whether live or dead bacteria were used for stimulation, it is intriguing that a much higher proportion of cd-T cells produced IFNc in response to live Salmonella compared with heat-killed Salmonella. The necessity of live Salmonella for induction of a T helper 1 response in the mouse has previously been described [39, 50, 68] and attributed to better IL-12 induction by live bacteria [51] . Our finding in relation to IFNc production by cd-T cells in man suggests that the cd-T cell subset may have an important role in protecting individuals from acute Salmonella infections.
IFNc production by the innate arm of the immune system produces a rapid response that may be key in controlling the early stages of infection. This, by itself, may not always be sufficient to clear Salmonella infection in man and prevention of persistent infection in the macrophage beds that can lead to recrudescence of infection. Studies in the mouse indicate that ab-T cells are not required during the first week of Salmonella infection [69, 70] and IFNc is produced in response to IL12 and IL18 in rag 2/2 and SCID mice that lack T cells [71] . These findings all support the concept that cells other than ab-T cells are responsible for production of the IFNc required for survival in the first week of Salmonella infection. Nevertheless, mice lacking ab-T cells fail to clear Salmonella and die later during Salmonella infection [31, 70, 72, 73, 74, 75] . Surprisingly, this clearance does not appear to involve IFNc, since depletion of this cytokine from day 6 of Salmonella infection in the mouse does not prevent bacterial clearance [76] . This raises the possibility that in many instances IFNc-production by ab-T cells is not required for immunity to Salmonella. In contrast, IL-2 has been found to enhance clearance of Salmonella in the mouse raising the possibility that this cytokine is more important than IFNc during the late response to Salmonella infection [77] .
Our study has potential implications in relation to the reduction of IFNc levels seen in HIV infection and the high susceptibility of Africans living with HIV/AIDS to NTS bacteremia. Since HIV targets cells that express CD4, especially CD4
+ -T cells, and decreased IFNc production in the context of HIV infection occurs in cells of the acquired immune system [45, 47] the finding of inherent capacity for IFNc production among innate cells could be exploited to therapeutic advantage. Expansion of non-CD4-expressing cells of the innate immune system with IFNc-producing capacity, in particular NK cells and cd-T cells, could compensate for lost IFNc production by CD4
+ -T cells, particularly in advanced HIV/AIDS. This could be used both in the prevention and treatment of invasive NTS disease in such individuals.
Our present findings indicate that the innate cellular arm of the immune system has an inherent capacity for production of IFNc. Taken in the context of other work on the role of antibody in protection against NTS bacteremia, these findings suggest that the primary requirement of a vaccine against NTS should be the induction of a protective antibody response against these bacteria. Without such antibody, serum bactericidal function [3] and the opsonic activity required for phagocyte cell function [17] are both abrogated leaving children vulnerable to both extracellular and intracellular growth of Salmonella. Prevention of persistent Salmonella infection with recrudescent disease, as commonly found in HIV-infected Africans [7] , is also an important goal of vaccination and this may require the development of a robust adaptive cellular response to NTS. Further insight into the need for this will be gained through the study of at-risk populations where the disease is most prevalent: young children and HIVinfected adults in sub-Saharan Africa.
